Cost Effectiveness of Second-Line Axicabtagene ciloleucel in Relapsed Refractory Diffuse Large B-cell Lymphoma. Kambhampati S, Saumoy M, Schneider Y, Serrao S, et al. Blood 2022 Aug 1. pii: 486082. doi: 10.1182/blood.2022016747.

Read + Share

Amedeo Smart

Independent Medical Education

Kambhampati S, Saumoy M, Schneider Y, Serrao S, et al. Cost Effectiveness of Second-Line Axicabtagene ciloleucel in Relapsed Refractory Diffuse Large B-cell Lymphoma. Blood 2022 Aug 1. pii: 486082. doi: 10.1182/blood.2022016747.
PMID: 35914220